The prior deal was listed as $12.00. Where this gets interesting is that Verigy said that its board of directors IS NOT MAKING A DECISION on the revised Advantest proposal at this time, and it anticipates continuing to engage in discussions with Advantest.
It further noted, “There can be no assurances that any transaction will result from the revised Advantest proposal or Verigy’s discussions with Advantest.”
As of now, Verigy continues to recommend and support the LTX-Credence merger agreement to its shareholders. It is also not withdrawing its recommendation to Verigy shareholders.
Verigy shares are now up 8% at $13.65 in very active trading. LTX-Credence shares are down another 5.4% at $7.37 and Advantest shares are up 0.5% at $22.49.
If Advantest really truly wants Verigy, maybe it should consider taking on LTX-Credence as well.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Top Gaining Stocks
Top Losing Stocks